| Views | |
|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 81 |
| February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | |
|---|---|---|---|---|---|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 1 | 1 | 1 | 4 | 3 | 6 | 0 |
| Views | |
|---|---|
| Gruzdeva_Risk management.pdf | 55 |
| Views | |
|---|---|
| United States | 26 |
| Germany | 5 |
| Canada | 3 |
| South Korea | 3 |
| Australia | 2 |
| Spain | 2 |
| India | 2 |
| Qatar | 2 |
| Vietnam | 2 |
| Bulgaria | 1 |
| Views | |
|---|---|
| Houston | 3 |
| Ottawa | 3 |
| Palo Alto | 3 |
| Doha | 2 |
| Fairfield | 2 |
| Hanoi | 2 |
| Mumbai | 2 |
| San Jose | 2 |
| White Plains | 2 |
| Baltimore | 1 |